Glaukos Corp. Income Statement
GKOS / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Glaukos Corp. reported $507M in revenue and $188M in net loss for FY2025. Revenue has grown at a 30.4% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.4M | $383.5M | $314.7M | $282.9M | $294.0M | $225.0M | $237.0M | $181.3M | $159.3M | $114.4M | $71.7M | $45.6M | $20.9M |
| Cost of Revenue | $111.8M | $94.0M | $75.6M | $69.0M | $66.6M | $91.7M | $38.6M | $25.1M | $21.1M | $16.2M | $13.0M | $11.4M | $2.5M |
| Gross Profit | $282.8M | $289.5M | $239.1M | $213.9M | $227.4M | $133.2M | $198.4M | $156.2M | $138.2M | $98.2M | $58.7M | $34.2M | $18.4M |
| SG&A Expense | $331.7M | $261.2M | $224.1M | $192.9M | $179.3M | $171.4M | $176.6M | $119.5M | $96.3M | $64.8M | $44.0M | $28.1M | $17.1M |
| R&D Expense | $150.6M | $136.4M | $138.8M | $123.3M | $101.0M | $85.4M | $68.3M | $10.9M | $38.9M | $29.2M | $25.0M | $19.2M | $15.5M |
| Operating Income | -$199.6M | -$122.4M | -$128.7M | -$82.3M | -$32.9M | -$123.6M | -$50.3M | -$13.0M | -$2.3M | $4.2M | -$10.3M | -$13.2M | -$14.2M |
| Interest Expense | - | - | $13.6M | $13.7M | $13.4M | $14.1M | $2.6M | - | - | - | - | - | - |
| Income Tax | -$5.4M | $771.0K | $934.0K | $766.0K | $326.0K | -$12.0M | -$65.5M | $583.0K | $93.0K | $43.0K | $33.0K | $18.0K | $6.0K |
| Net Income | -$187.7M | -$146.4M | -$134.7M | -$99.2M | -$49.6M | -$120.3M | $15.4M | -$13.0M | -$92.0K | $4.5M | -$37.2M | -$12.1M | -$12.6M |
| EPS (Basic) | -$2.78 | -$2.09 | -$1.07 | -$2.70 | $0.41 | -$0.37 | $0.00 | $0.14 | -$2.13 | -$5.29 | -$0.40 | -$5.29 | - |
| EPS (Diluted) | -$2.78 | -$2.09 | -$1.07 | -$2.70 | $0.37 | -$0.37 | $0.00 | $0.12 | -$2.13 | -$5.29 | -$0.40 | -$5.29 | - |
| Shares Outstanding | 56.4M | 49.1M | 47.8M | 47.0M | 45.2M | 43.5M | 36.1M | 34.6M | 33.9M | 32.2M | 2.4M | 2.3M | 2.0M |
| Gross Margin | 55.7% | 75.5% | 76.0% | 75.6% | 77.3% | 59.2% | 83.7% | 86.2% | 86.8% | 85.9% | 81.9% | 75.0% | 87.9% |
| Operating Margin | -39.3% | -31.9% | -40.9% | -29.1% | -11.2% | -54.9% | -21.2% | -7.2% | -1.4% | 3.7% | -14.4% | -28.9% | -67.8% |
| Profit Margin | -37.0% | -38.2% | -42.8% | -35.1% | -16.9% | -53.5% | 6.5% | -7.1% | -0.1% | 4.0% | -51.9% | -26.6% | -60.3% |